Pre-validated for trans-epidermal efficacy, cellular safety, and shelf-life stability under international regulatory parameters.
The contemporary global dermo-cosmetic sector has permanently transitioned from commoditized contract filling toward advanced, science-backed Original Design Manufacturing (ODM). Independent beauty brands, multi-location dermatological clinic chains, and global e-commerce conglomerates demand contract manufacturing partners that operate not merely as mechanical assemblers, but as proprietary biotechnology incubators capable of safeguarding intellectual property, navigating fractured regulatory ecosystems, and executing hyper-pure active delivery systems.
Historically, contract cosmetic manufacturing suffered from elongated development cycles, lack of empirical stability validation, and opaque raw material provenance. In today's volatile omnichannel beauty economy, an ODM partner must master the entire value chain: from target gene-expression peptides and bio-fermented postbiotics down to microfluidic emulsification, sustainable primary packaging compatibility, and accelerated regulatory dossier compilation.
Strategic Mandate: True ODM excellence synthesizes deep biochemical compound databases with high-speed automated robotic filling lines, dramatically mitigating supply-chain volatility while maximizing formulation efficacy.
By owning two modern production subsidiaries in Guangzhou—Guangzhou Aoyan Cosmetics Co., Ltd. and Guangzhou Xinzimei Cosmetics Co., Ltd.—our ecosystem bypasses intermediary commercial trading friction. We preserve raw active potency under strict Class 100,000 cleanroom atmospheres, enabling institutional clients to secure tier-one production slots without margin degradation.
Strategic formulation vectors engineered to satisfy evolving consumer demographics and stringent global clean-beauty guidelines.
Formulations formulated with adaptogenic neuropeptides that calm skin cortisol responses while reconstructing the cellular lipid bilayer with biomimetic ceramides (NP, AP, EOP), phytosphingosine, and fermented squalane.
Transitioning from petrochemical synthesis to precision microbial fermentation. Producing recombinant human-derived collagen types I, III, and XVII alongside non-animal extracellular vesicles for enhanced trans-dermal signaling.
Live-filtered cell-free lysates and stabilized postbiotic metabolites engineered to reinforce commensal skin flora, inhibiting Cutibacterium acnes and Staphylococcus aureus colonization without triggering barrier sensitization.
Mitigate cross-border border delays and confiscations with formulation matrixes optimized for the regulatory nuances of primary cosmetic markets.
| Target Jurisdiction | Statutory Regulatory Framework | Formulation Restraints & Actives Strategy | Pre-Shipment Documentation Suite |
|---|---|---|---|
| North America (USA & Canada) | FDA MoCRA (Modernization of Cosmetics Regulation Act), Health Canada Cosmetic Notification (CNF) | Strict trace-heavy-metal testing (1,4-Dioxane <10ppm, Lead <10ppm), PFAS-free certification, state-level California Prop 65 compliance. | FDA Establishment Registration, Facility Listing, Batch COA, Safety Substantiation Dossier, MoCRA RP Designation. |
| European Union & UK | EU Regulation (EC) No 1223/2009, UK Cosmetic Regulations (Schedule 34) | Total avoidance of CMR 1A/1B substances, strict restriction on Lilial, cyclic silicones (D4, D5), microplastics ban compliance, nanomaterial declaration. | Full Cosmetic Product Safety Report (CPSR Part A & B), Product Information File (PIF), EU CPNP & UK SCPN Portal Filing. |
| Middle East & GCC | SASO (GSO 1943:2021), UAE ESMA, SFDA Cosmetic Compliance | Zero-ethanol content certification, Halal-compliant animal-free source verification, pork-derivative elimination, photostability in hyper-arid climates. | SASO Certificate of Conformity (CoC), SFDA e-Clearance, Certificate of Free Sale (CFS), Halal Audit Traceability. |
| Asia-Pacific (APAC) | China NMPA CSAR, ASEAN Cosmetic Directive (ACD), Japan PMDA | Stringent INCI nomenclature localization, safety assessment dossiers, positive active list registration for functional whitening/anti-spot claims. | Responsible Agent Registration, Microbiological Challenge Test Reports, Batch Retention Documentation, COA. |
The core bottleneck of therapeutic skincare formulation is the stratum corneum—the biological shield designed by nature to prevent exogenous penetration. Our proprietary technical roadmap deploys triple-phase submicron liposomes, solid lipid nanoparticles (SLNs), and cyclodextrin supramolecular cages. These platforms protect unstable actives (such as L-Ascorbic Acid, Retinoids, and Oligopeptides) from light, oxidation, and enzymatic decomposition until they reach targeted dermal depths.
Coupled with our high-shear microfluidic homogenizers operating at 1,200 bar, active droplets achieve uniform sub-200nm dispersion, yielding luxurious texture profiles, non-greasy sensory finishes, and extended 36-month shelf life stability verified under extreme 45°C/75% RH challenge chambers.
Primary Packaging Engineering: Active efficacy requires barrier protection. We provide airless EVOH multi-layer bottles, amber medical-grade borosilicate vials, and recyclable PCR-PP pump dispensers engineered for minimal oxidation.
Our collaborative formula indexing engine matches brand concept constraints against 3,500+ archived, batch-tested benchmark bases in real time, accelerating prototype formulation from months down to 72 hours.
Protocols encompass centrifuge freeze-thaw (-15°C to +48°C cycles), mechanical vibration stress tests for maritime freight, and USP 51 antimicrobial efficacy evaluation across bacteria, yeasts, and molds.
A structured, predictable manufacturing pipeline designed to prevent operational bottlenecks, minimize launch risks, and secure rapid time-to-market.
Product briefing, retail pricing targets, target regulatory compliance checks, and OEM versus ODM route determination.
Lab prototyping, sensory optimization, texture adjustment, viscosity calibration, and packaging compatibility testing.
Primary/secondary packaging proofing, INCI ingredient declaration, MSDS, COA, and CPSR/PIF document compilation.
Class 100,000 cleanroom vacuum emulsification, automated high-speed multi-head filling, and continuous in-line visual inspection.
Palletized air, rail, or maritime shipping with comprehensive export customs clearance documentation, CFS, and bill of lading issuance.
Formulated to capture high margin clinical, medical spa, and retail skin care market segments worldwide.
Direct operational answers addressing formula stability, intellectual property protection, minimum order economics, and regulatory clearance.
In the OEM (Original Equipment Manufacturer) framework, the client provides their own pre-validated formulation chemistry, explicit raw material specifications, and batch mixing parameters; Beaza serves as the precision contract manufacturing and filling facility. In the ODM (Original Design Manufacturer) model, the brand accesses our proprietary scientific database containing over 3,500 market-tested master formulations. We oversee custom active tailoring, stability challenge testing, package material engineering, and full legal documentation under the brand's sovereign label name.
Our manufacturing sites operate under international cGMP protocols, verified by ISO 22716:2007 (Cosmetics GMP) and US FDA Cosmetics Establishment registration, alongside full BSCI social compliance audits. For cross-border logistics, we supply comprehensive safety dossiers including GHS-compliant 16-section Safety Data Sheets (MSDS), Certificate of Analysis (COA) per production lot, heavy metal/microbial assay certificates, Certificate of Free Sale (CFS), and verified dossiers for EU CPNP notifications, CPSR Part A/B, and Saudi SASO conformity certificates.
Every custom or private label formula undergoes rigorous stability profiling inside programmable thermal humidity chambers. We perform freeze-thaw cycles (-10°C to +45°C over 28 consecutive days), centrifugal shear separation checks (3,000 RPM for 30 minutes), and UV/light photo-degradation analysis. These steps ensure that emulsions, toners, and lipid matrices prevent phase inversion, syneresis, discoloration, or viscosity drop in tropical, arid, or sub-zero retail delivery environments.
Yes. Our in-house research laboratory specializes in green biotechnology formulations compliant with Credo, Sephora Clean, and ISO 16128 natural cosmetic indexes. We utilize non-paraben, non-phenoxyethanol multi-functional booster systems (such as Caprylyl Glycol, Hydroxyacetophenone, and Glyceryl Caprylate) that provide robust broad-spectrum microbial protection while qualifying for sensitive-skin hypoallergenic and vegan certification standards.
Our minimum order requirements are structured to support brand growth. Turnkey ODM projects leveraging our validated library formulations begin at accessible MOQs (typically 1,000 to 3,000 units depending on primary packaging components). Bespoke, ground-up clinical formulations requiring novel active sourcing generally start at 5,000 units. Standard laboratory sample dispatch takes 3–5 working days; mass industrial emulsification and automated filling are completed within 15–25 business days following final artwork and packaging arrival.
Strict non-disclosure agreements (NDAs) govern all client consultations and proprietary projects. Formula revisions, specialized peptide inclusion ratios, and unique functional fragrance profiles developed exclusively for your brand remain your exclusive operational asset. Beaza enforces strict zero-leakage intellectual property protocols across internal digital formulation records and physical compounding logbooks.